InspireMD, Inc.
NSPRNASDAQHealthcare● Active
$0.82
$-0.06(-7.24%)
Market Cap$38234676
P/E Ratio—
52W High$2.93
52W Low$0.8
InspireMD, Inc. (NSPR) Earnings: Dates, EPS & Revenue History
Quarterly EPS vs. estimates, revenue surprises, next earnings date, and analyst consensus.
NSPR · earnings · updated Jun 9, 2026
Latest Earnings
Q2 FY2026Report Date: May 4, 2026EPS Actual
-$0.16
Est. -$0.19 · +15.8%
Revenue
$0.00B
Est. $0.00B · +25.8%
Fiscal Period
Q2 FY2026
FY ends December
Report Date
May 4, 2026
After Market Close
▲ Beat EPS▲ Beat Revenue✓ 3-Quarter EPS Beat Streak
NSPR reports quarterly as a NASDAQ-listed Medical - Devices company. Fiscal year ends in December. Data: FMP · Updated hourly.
Next Earnings Date
Days Away
84
days
Expected Date
Sep 1, 2026
Fiscal Period
Q3 FY2026
Release Time
◌ Time TBD (Unconfirmed)EPS Est.
$1.00
Rev. $1.80B
Days Away84
Expected DateSep 1, 2026
Fiscal PeriodQ3 FY2026
Release TimeTime TBD (Unconfirmed)
EPS Est.$1.00
Rev. Est.$1.80B
EPS & Revenue vs. Estimates
Actual (Beat)
Actual (Miss)
Estimated
Earnings History
| Period | Report Date | EPS Est. | EPS Actual | EPS Surpr. | Revenue | Rev. Est. | Rev. Surpr. |
|---|---|---|---|---|---|---|---|
| ◌ Q3 FY2026 | Aug 3, 2026 | -$0.20 | — | — | — | $0.00B | — |
| ▲ Q2 FY2026 | May 4, 2026 | -$0.19 | -$0.16 | +15.8% | $0.00B | $0.00B | +25.8% |
| ▲ Q1 FY2026 | Mar 18, 2026 | -$0.22 | -$0.14 | +36.4% | $0.00B | $0.00B | +19.9% |
| — Q4 FY2025 | Nov 4, 2025 | -$0.17 | -$0.17 | +0.0% | $0.00B | $0.00B | -4.0% |
| ▼ Q3 FY2025 | Aug 4, 2025 | -$0.24 | -$0.26 | -8.3% | $0.00B | $0.00B | +1.1% |
| ▼ Q2 FY2025 | May 9, 2025 | -$0.17 | -$0.22 | -29.4% | $0.00B | $0.00B | +1.9% |
| ▲ Q1 FY2025 | Mar 12, 2025 | -$0.20 | -$0.19 | +5.0% | $0.00B | $0.00B | +34.2% |
| ▲ Q4 FY2024 | Nov 12, 2024 | -$0.20 | -$0.16 | +20.0% | $0.00B | $0.00B | -1.3% |
Q3 FY2026
Aug 3, 2026
EPS Actual
—
EPS Est.
-$0.20
EPS Surpr.
—
Revenue
—
Q2 FY2026
May 4, 2026Beat
EPS Actual
-$0.16
EPS Est.
-$0.19
EPS Surpr.
+15.8%
Revenue
$0.00B
Q1 FY2026
Mar 18, 2026Beat
EPS Actual
-$0.14
EPS Est.
-$0.22
EPS Surpr.
+36.4%
Revenue
$0.00B
Q4 FY2025
Nov 4, 2025
EPS Actual
-$0.17
EPS Est.
-$0.17
EPS Surpr.
+0.0%
Revenue
$0.00B
Q3 FY2025
Aug 4, 2025Miss
EPS Actual
-$0.26
EPS Est.
-$0.24
EPS Surpr.
-8.3%
Revenue
$0.00B
Q2 FY2025
May 9, 2025Miss
EPS Actual
-$0.22
EPS Est.
-$0.17
EPS Surpr.
-29.4%
Revenue
$0.00B
Q1 FY2025
Mar 12, 2025Beat
EPS Actual
-$0.19
EPS Est.
-$0.20
EPS Surpr.
+5.0%
Revenue
$0.00B
Q4 FY2024
Nov 12, 2024Beat
EPS Actual
-$0.16
EPS Est.
-$0.20
EPS Surpr.
+20.0%
Revenue
$0.00B
Analyst Estimates
Limited analyst coverage (fewer than 3 analysts). Estimates may not reflect market consensus.
EPS Estimates
| Period | Low | Consensus | High | # Analysts |
|---|---|---|---|---|
| Q4 FY2027 | $-0.22 | $-0.19 | $-0.16 | 1 |
| Q3 FY2027 | $-0.14 | $-0.12 | $-0.10 | 1 |
| Q2 FY2027 | $-0.11 | $-0.09 | $-0.07 | 1 |
| Q1 FY2027 | $-0.09 | $-0.08 | $-0.07 | 1 |
| Q4 FY2026 | $-0.22 | $-0.19 | $-0.16 | 1 |
| Q3 FY2026 | $-0.22 | $-0.19 | $-0.16 | 2 |
Revenue Estimates
| Period | Low | Consensus | High | # Analysts |
|---|---|---|---|---|
| Q4 FY2027 | $0.0B | $0.0B | $0.0B | 1 |
| Q3 FY2027 | $0.0B | $0.0B | $0.0B | 1 |
| Q2 FY2027 | $0.0B | $0.0B | $0.0B | 1 |
| Q1 FY2027 | $0.0B | $0.0B | $0.0B | 1 |
| Q4 FY2026 | $0.0B | $0.0B | $0.0B | 1 |
| Q3 FY2026 | $0.0B | $0.0B | $0.0B | 2 |
Earnings Price Reaction
Closing price one trading day before vs. one trading day after each earnings release.
| Period | Report Date | EPS Beat/Miss | Price Before | Price After | 1D Reaction |
|---|---|---|---|---|---|
| ▲ Q2 FY2026 | May 4, 2026 | +15.8% | $1.15 | $1.17 | +1.74% |
| ▲ Q1 FY2026 | Mar 18, 2026 | +36.4% | $1.79 | $1.79 | +0.00% |
| ▲ Q4 FY2025 | Nov 4, 2025 | +0.0% | $2.29 | $2.13 | -6.99% |
| ▼ Q3 FY2025 | Aug 4, 2025 | -8.3% | $2.69 | $2.67 | -0.74% |
| ▼ Q2 FY2025 | May 9, 2025 | -29.4% | $2.60 | $2.60 | +0.00% |
| ▲ Q1 FY2025 | Mar 12, 2025 | +5.0% | $2.79 | $2.81 | +0.72% |
| ▲ Q4 FY2024 | Nov 12, 2024 | +20.0% | $2.46 | $2.38 | -3.25% |
| ▼ Q3 FY2024 | Aug 6, 2024 | -15.8% | $2.96 | $2.98 | +0.68% |
Q2 FY2026+1.74%
Report Date
May 4, 2026
EPS Beat/Miss
+15.8%
Price Before
$1.15
Price After
$1.17
Q1 FY2026+0.00%
Report Date
Mar 18, 2026
EPS Beat/Miss
+36.4%
Price Before
$1.79
Price After
$1.79
Q4 FY2025-6.99%
Report Date
Nov 4, 2025
EPS Beat/Miss
+0.0%
Price Before
$2.29
Price After
$2.13
Q3 FY2025-0.74%
Report Date
Aug 4, 2025
EPS Beat/Miss
-8.3%
Price Before
$2.69
Price After
$2.67
Q2 FY2025+0.00%
Report Date
May 9, 2025
EPS Beat/Miss
-29.4%
Price Before
$2.60
Price After
$2.60
Q1 FY2025+0.72%
Report Date
Mar 12, 2025
EPS Beat/Miss
+5.0%
Price Before
$2.79
Price After
$2.81
Q4 FY2024-3.25%
Report Date
Nov 12, 2024
EPS Beat/Miss
+20.0%
Price Before
$2.46
Price After
$2.38
Q3 FY2024+0.68%
Report Date
Aug 6, 2024
EPS Beat/Miss
-15.8%
Price Before
$2.96
Price After
$2.98
Avg Beat Reaction-1.56%
Avg Miss Reaction-0.02%
Beat Rate5 / 8 quarters
Largest Move-6.99% (Q4 FY2025)
Data: FMP /historical-price-eod/full · field: close
About Earnings & Data Methodology
Data source: Financial Modeling Prep (FMP) | Updated: Hourly | Surprise%: (Actual − Estimate) / |Estimate| × 100 | Fiscal year: NSPR ends December
InspireMD, Inc. (NSPR) most recently reported earnings on May 4, 2026 for Q2 FY2026, posting EPS of $-0.16 — beating the analyst consensus of $-0.19 by +15.8%. NSPR has beaten EPS estimates for 3 consecutive quarters. The next NSPR earnings date is expected around September 1, 2026.
Each quarter, investors track NSPR earnings for signals on forward guidance and business momentum. For longer-term revenue trends, see the Revenue tab. NSPR revenue tab →
Earnings Glossary
EPS (Earnings Per Share)
Net income ÷ diluted shares outstanding. The primary metric analysts use to gauge quarterly profitability.
Earnings Surprise %
(Actual − Estimate) / |Estimate| × 100. Positive = Beat. Negative = Miss.
Beat / Miss / In-Line
Beat = Actual ≥ Estimate. Miss = Actual < Estimate. In-Line = within ±1%.
BMO / AMC
Before Market Open / After Market Close. Two windows when companies typically release results.
Fiscal Quarter
NSPR's fiscal year ends in December. Fiscal quarters may not align with calendar quarters.
Analyst Consensus
Average EPS/Revenue forecast across all covering analysts. More analysts = more reliable estimate.
Figures tie to FMP earnings calendar, estimates, and SEC 10-Q/10-K filings where noted.
Frequently asked questions
NSPR earnings · 5 questionsInspireMD, Inc.'s next earnings report is expected around September 1, 2026. NSPR typically reports quarterly — approximately every three months. The exact date is confirmed by the company 2–4 weeks before the release. Time is currently TBD; NSPR historically reports after market close (AMC).
NSPR earnings datewhen is NSPR earningsNSPR next earnings datewhen does NSPR report earningsNSPR earnings calendar
▸ Source: FMP · InspireMD, Inc. SEC filings · US GAAP · InspireMD, Inc. SEC 10-K & 10-Q filings · US GAAP · Updated: Jun 9, 2026